IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks38AK.L Regulatory News (38AK)

  • There is currently no data for 38AK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Prospectus

21 Nov 2012 14:45

RNS Number : 7198R
Barclays Bank PLC
21 November 2012
 



Publication of Prospectus

 

The following prospectus has been approved by the UK Listing Authority and is available for viewing:

 

Prospectus dated 19 November 2012 for the Barclays Bank PLC issuance of U.S.$3,000,000,000 7.625 per cent. Contingent Capital Notes due November 2022

 

To view the full document, please paste the following URL into the address bar of your browser.

 

http://www.rns-pdf.londonstockexchange.com/rns/7198R_1-2012-11-21.pdf 

 

A copy of the above document has been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.Hemscott.com/nsm.do

 

For further information, please contact

 

Barclays Treasury

1 Churchill Place

Canary Wharf

London E14 5HP

 

 

DISCLAIMER - INTENDED ADDRESSEES

 

IMPORTANT: You must read the following before continuing: The following applies to the Prospectus available by clicking on the link above, and you are therefore advised to read this carefully before reading, accessing or making any other use of the Prospectus. In accessing the Prospectus, you agree to be bound by the following terms and conditions, including any modifications to them, any time you receive any information from us as a result of such access.

THE PROSPECTUS MAY NOT BE FORWARDED OR DISTRIBUTED OTHER THAN AS PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY MANNER WHATSOEVER. THE PROSPECTUS MAY ONLY BE DISTRIBUTED OUTSIDE THE UNITED STATES TO PERSONS THAT ARE NOT U.S. PERSONS AS DEFINED IN, AND IN RELIANCE ON, REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"). ANY FORWARDING, DISTRIBUTION OR REPRODUCTION OF THE PROSPECTUS IN WHOLE OR IN PART IS PROHIBITED. FAILURE TO COMPLY WITH THIS NOTICE MAY RESULT IN A VIOLATION OF THE SECURITIES ACT OR THE APPLICABLE LAWS OF OTHER JURISDICTIONS.

NOTHING IN THIS ELECTRONIC PUBLICATION CONSTITUTES AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION.

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Confirmation of your Representation: In order to be eligible to view the Prospectus, you must be a person other than a U.S. person (within the meaning of Regulation S under the Securities Act) viewing this Prospectus outside the United States. By accessing the Prospectus, you shall be deemed to have represented that you are outside the United States and are not a U.S. person.

You are reminded that the Prospectus has been made available to you on the basis that you are a person into whose possession the Prospectus may be lawfully delivered in accordance with the laws of the jurisdiction in which you are located and you may not, nor are you authorised to, deliver the Prospectus to any other person.

The Prospectus does not constitute, and may not be used in connection with, an offer or solicitation in any place where offers or solicitations are not permitted by law. If a jurisdiction requires that the offering be made by a licensed broker or dealer and the underwriters or any affiliate of the underwriters is a licensed broker or dealer in that jurisdiction, the offering shall be deemed to be made by the underwriters or such affiliate on behalf of the issuers in such jurisdiction. Under no circumstances shall the Prospectus constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of any Notes issued or to be issued pursuant to the Prospectus, in any jurisdiction in which such offer, solicitation or sale would be unlawful.

The Prospectus has been made available to you in an electronic form. You are reminded that documents transmitted via this medium may be altered or changed during the process of electronic transmission and consequently none of the issuers, their advisers nor any person who controls any of them nor any director, officer, employee nor agent of it or affiliate of any such person accepts any liability or responsibility whatsoever in respect of any difference between the Prospectus made available to you in electronic format and the hard copy version available to you on request from the issuers.

Notice to US investors: The Issuer has filed a registration statement on Form F-3 (including a prospectus which is different from the Prospectus) with the Securities and Exchange Commission (the "SEC") for the offering to which this communication relates and the Notes are being sold pursuant to that registration statement and prospectus. Before you invest, you should read the prospectus in that registration statement, the prospectus supplement relating to the Notes and the other documents that the Issuer has filed with the SEC for more complete information about the Issuer and the offering of the Notes. Copies of these documents may be obtained from Barclays Capital Inc. through Broadgate Integrated Prospectus Distribution, 1155 Long Island Avenue, New York, NY 11717, United States of America. Alternatively, these documents are available at no charge by visiting EDGAR on the SEC website at www.sec.gov.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PDIBKDDNQBDDFDB
Date   Source Headline
31st May 20138:38 amRNSStabilisation Notice
15th May 20132:30 pmRNSPublication of Base Prospectus
1st May 20139:00 amRNSBarclays Corporate Banking Investor Presentation
24th Apr 20137:00 amRNSInterim Management Statement
22nd Apr 20139:00 amRNSDirectorate Change
18th Apr 201311:00 amRNSBarclays Announces Senior Management Changes
18th Apr 20139:14 amRNSStabilisation Notice - Bupa
16th Apr 201312:19 pmRNS2012 & 2011 Restatement Document
14th Mar 20133:31 pmRNSAnnual Report on Form 20F
8th Mar 201311:00 amRNSAnnual Financial Report
19th Feb 20134:21 pmRNSPublication of Base Prospectus Supplement
13th Feb 20132:10 pmRNSExercise of Warrants
12th Feb 20132:00 pmRNSFinal Results
12th Feb 201312:02 pmRNSOutcome of Strategic Review & Commitments for 2015
12th Feb 20137:00 amRNSOutcome of Strategic Review & Commitments for 2015
12th Feb 20137:00 amRNSFinal Results
5th Feb 20133:05 pmRNSMerger Update
5th Feb 20137:00 amRNSDirectorate Change
5th Feb 20137:00 amRNSProvisions: Interest Rate Hedging Products & PPI
4th Feb 20137:00 amRNSManagement Changes
24th Jan 20139:45 amRNSNotice to Covered Bondholders
17th Jan 20133:00 pmRNSMerger Update
14th Jan 20134:13 pmRNSStabilisation Notice
10th Dec 201210:23 amRNSStabilisation Notice
6th Dec 20127:00 amRNSBarclays & Absa agree to combine Africa operations
29th Nov 20122:53 pmRNSInterim Report 30.06.2012
29th Nov 20122:53 pmRNSInterim Management Statement 30.09.2012
21st Nov 20122:45 pmRNSPublication of Prospectus
21st Nov 20129:28 amRNSStabilisation Notice
15th Nov 20127:00 amRNSRedemption of Notes and Cancellation of Listing
7th Nov 20125:20 pmRNSPublication of Base Prospectus Supplement
31st Oct 20127:00 amRNSInterim Management Statement
15th Oct 201211:10 amRNSBoard Change
9th Oct 20127:00 amRNSBarclays to acquire ING Direct UK
18th Sep 20124:41 pmRNSInvitation to Purchase Notes for Cash (Results)
18th Sep 20124:37 pmRNSInvitation to Purchase Notes for Cash (Results)
10th Sep 20125:06 pmRNSInvitation to Purchase Notes for Cash
10th Sep 20125:03 pmRNSInvitation to Purchase Notes for Cash
30th Aug 20127:00 amRNSAntony Jenkins appointed as Group Chief Executive
21st Aug 20127:00 amRNSDiscussions with Absa to combine Africa operations
14th Aug 20123:35 pmRNSPublication of Base Prospectus Supplement
27th Jul 20122:00 pmRNSHalf Yearly Report
27th Jul 20127:00 amRNSHalf Yearly Report
25th Jul 201212:00 pmRNSBoard Change
17th Jul 20129:57 amRNSRedemption of Notes and Cancellation of Listing
10th Jul 201210:14 amRNSAgreement with Bob Diamond following resignation
3rd Jul 20127:30 amRNSBoard changes
2nd Jul 20127:00 amRNSBoard changes
29th Jun 201212:42 pmRNSRe FSA Stmt on Interest Rate Hedging Products
27th Jun 20121:30 pmRNSBarclays Bank PLC Settlement with Authorities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.